A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE Studies.

Huang, David B; Noviello, Stephanie; Balser, Barbara; Scaramucci, Amy; Corey, G Ralph

Huang, David B; Noviello, Stephanie; Balser, Barbara; Scaramucci, Amy; Corey, G Ralph.

Affiliation

Huang DB; Motif BioSciences, Princeton, NJ, USA; Rutgers New Jersey Medical School, Trenton, NJ, USA. Electronic address: david.huang@motifbio.com.
Noviello S; Motif BioSciences, Princeton, NJ, USA.
Balser B; Veristat, Southborough, MA, USA.
Scaramucci A; Veristat, Southborough, MA, USA.
Corey GR; Duke University Medical Center, Durham, NC, USA.

Clin Ther ; 41(6): 1090-1096, 2019 06.

Article in En | MEDLINE | ID: mdl-31030995

Subject(s)

Anti-Bacterial Agents; Pyrimidines; Skin Diseases, Bacterial; Substance Abuse, Intravenous/complications; Vancomycin; Administration, Intravenous; Anti-Bacterial Agents/administration & dosage; Anti-Bacterial Agents/adverse effects; Anti-Bacterial Agents/therapeutic use; Double-Blind Method; Humans; Pyrimidines/administration & dosage; Pyrimidines/adverse effects; Pyrimidines/therapeutic use; Skin Diseases, Bacterial/complications; Skin Diseases, Bacterial/drug therapy; Treatment Outcome; Vancomycin/administration & dosage; Vancomycin/adverse effects; Vancomycin/therapeutic use

Key words

iclaprim; intravenous drug use; skin infection; vancomycin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Vancomycin / Substance Abuse, Intravenous / Skin Diseases, Bacterial / Anti-Bacterial Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Ther Year: 2019 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google